These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19710075)

  • 21. Antimicrobial susceptibilities of strains of Nocardia brasiliensis isolated from soil of Tucumán.
    van Gelderen de Komaid AA; Durán EL
    Mycopathologia; 1998; 141(3):115-21. PubMed ID: 9755502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
    Sahm DF; Deane J; Bien PA; Locke JB; Zuill DE; Shaw KJ; Bartizal KF
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):112-8. PubMed ID: 25488274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
    Pfaller MA; Flamm RK; Jones RN; Farrell DJ; Mendes RE
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5393-9. PubMed ID: 27353270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.
    Rodríguez-Avial I; Culebras E; Betriu C; Morales G; Pena I; Picazo JJ
    J Antimicrob Chemother; 2012 Jan; 67(1):167-9. PubMed ID: 21954458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones.
    Hernandez-Hernandez F; Lopez-Martinez R; Mendez-Tovar LJ; Manzano-Gayosso P
    Mycopathologia; 1995 Nov; 132(2):79-85. PubMed ID: 8819830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tedizolid: a novel oxazolidinone for Gram-positive infections.
    Moellering RC
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S1-3. PubMed ID: 24343826
    [No Abstract]   [Full Text] [Related]  

  • 27. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
    Glupczynski Y; Berhin C; Janssens M; Wauters G
    Clin Microbiol Infect; 2006 Sep; 12(9):905-12. PubMed ID: 16882297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Nocardia species.
    Lerner PI; Baum GL
    Antimicrob Agents Chemother; 1973 Aug; 4(2):85-93. PubMed ID: 4790942
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Brown-Elliott BA; Wallace RJ
    J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe.
    Bensaci M; Sahm D
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):133-138. PubMed ID: 27866673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic].
    Yazawa K; Mikami Y; Otozai K; Uno J; Arai T
    Jpn J Antibiot; 1989 Nov; 42(11):2354-62. PubMed ID: 2695658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
    Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
    J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro sensitivity of Nocardia brasiliensis to various antibiotics and therapeutic drugs].
    Minami PS; Junqueira Martins JB; Parra DS
    Rev Farm Bioquim Univ Sao Paulo; 1974; 12(2):147-63. PubMed ID: 4468453
    [No Abstract]   [Full Text] [Related]  

  • 34. Actinomycetoma and advances in its treatment.
    Welsh O; Vera-Cabrera L; Welsh E; Salinas MC
    Clin Dermatol; 2012; 30(4):372-81. PubMed ID: 22682184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.
    Biedenbach DJ; Bouchillon SK; Johnson B; Alder J; Sahm DF
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1933-1939. PubMed ID: 27677280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
    Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diaminodiphenyl-sulphone: in vitro activity alone and in combination with other antimicrobials against 30 strains of Nocardia brasiliensis.
    Gonzalez-Benavides N; Vera-Cabrera L; Sanchez-Meza E; Ocampo-Candiani J; Welsh O
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e395-e396. PubMed ID: 31063602
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.
    Yamagishi Y; Mikamo H; Kato H; Nishiyama N; Asai N; Koizumi Y; Sakanashi D; Suematsu H; Matsuura K; Hagihara M
    J Infect Chemother; 2017 Jun; 23(6):368-373. PubMed ID: 28343752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid.
    D'Andrea S; Zheng ZB; Denbleyker K; Fung-Tomc JC; Yang H; Clark J; Taylor D; Bronson J
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2834-9. PubMed ID: 15911264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.